Spinal Muscular Atrophy (SMA) is a devastating inherited neuromuscular disorder and a primary genetic cause of infant mortality. At its core, the disease is characterized by the progressive degeneration of motor neurons within the spinal cord, a process that leads to severe muscle weakness and loss of motor function. While the genetic origin of SMA is well-defined, recent research highlights that the pathology is not merely a matter of protein deficiency, but a profound disruption of cellular energy dynamics—specifically involving the mitochondria.
The Genetic Basis: SMN1 and the SMN Protein
The primary driver of SMA is a mutation in the survival motor neuron 1 (SMN1) gene. This gene is responsible for encoding the SMN protein, an essential RNA-binding protein. In a healthy cell, the SMN protein plays a vital role in the development of nerve axons and dendrites, as well as ensuring the efficient transmission of electrical impulses between neurons and their target muscles.
The distribution of this protein is not uniform; the highest levels of SMN protein are found in the spinal cord, underscoring its critical importance to the nervous system. When SMN levels are deficient due to genetic mutations, the cellular machinery required to maintain nerve integrity begins to fail.
Mitochondrial Homeostasis and Biogenesis
Mitochondria are the "powerhouses" of the cell, responsible for producing the ATP required for almost all biological processes. Because they are so energy-intensive, tissues such as the spinal cord, skeletal muscle, and heart are particularly vulnerable to any disruption in mitochondrial health.
The SMN protein acts as a modulator for the expression of various mitochondrial proteins. Consequently, a loss of SMN disrupts two fundamental processes:
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
Continue reading freeAlready have an account? Log in
Updated